In addition, acute administration of TRPA1 antagonists (within 30 min to 5 h after treatment) significantly inhibited inflammatory-mediated itch (41) as well as in murine models of contact dermatitis (15). The gene discussed is TRPA1; the disease is contact dermatitis.